Prot #HCRN GU16-260: NU G17U11: Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma (BMS CA209-669)

Project: Research project

Project Details

Effective start/end date11/21/1711/21/26


  • Hoosier Cancer Research Network, Inc. ((OE) Prot #HCRN GU16-260 // (OE) Prot #HCRN GU16-260)
  • Georgetown University ((OE) Prot #HCRN GU16-260 // (OE) Prot #HCRN GU16-260)